Literature DB >> 9032509

The effect of dipyridamole and theophylline on hypercapnic ventilatory responses: the role of adenosine.

T L Griffiths1, J M Christie, S T Parsons, S T Holgate.   

Abstract

The purine nucleoside, adenosine, has been implicated as a neuromodulator in central respiratory depression during prolonged exposure to hypoxia. It may also be a mediator of hypoxic hyperpnoea, acting on the carotid bodies. As there may be adenosine-sensitive mechanisms of hypoxic respiratory control, we sought to determine whether adenosine might be involved as a respiratory modulator in another central but non-oxygen-related control mechanism, the ventilatory response to hyperoxic hypercapnia. Twelve normal subjects were studied following 3 days of oral treatment with placebo, dipyridamole (which potentiates adenosine effects by inhibiting cellular uptake), and theophylline (a specific adenosine antagonist of cell surface receptors). The drugs were given in a random order, double-blind fashion. Resting end-tidal carbon dioxide tension (PET,CO2) and the maximum rate of isometric inspiratory pressure change at the mouth ((dP/dt) max), an index of respiratory drive, were determined in all subjects on each treatment. Hyperoxic, hypercapnic ventilatory responses were determined in seven of these subjects using a rebreathing technique. For each hypercapnic response, minute ventilation (V1E) and (dP/dt) max were plotted against PET,CO2 breath-by-breath. Resting PET,CO2 breathing room air was lower with theophylline (5.47 (SD 0.21) kPa) than with placebo (5.74 (0.26) kPa) or dipyridamole (5.86 (0.34) kPa), with no significant drug differences in resting (dP/dt)max. However, neither the slope nor the PET, CO2 intercept of the relationship between ventilation or respiratory drive and PET, CO2 were altered by the study drugs under hyperoxic conditions. We conclude that endogenous adenosine-related mechanisms are unlikely to be involved in determining either the sensitivity or the threshold of the ventilatory response to carbon dioxide under hyperoxic conditions. However, in normoxia, a centrally-acting, tonic, adenosine-mediated, respiratory modulation is not ruled out.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032509     DOI: 10.1183/09031936.97.10010156

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

Review 1.  Purines, the carotid body and respiration.

Authors:  S Lahiri; C H Mitchell; D Reigada; A Roy; N S Cherniack
Journal:  Respir Physiol Neurobiol       Date:  2007-02-24       Impact factor: 1.931

2.  The Quintiles Prize Lecture 2004. The identification of the adenosine A2B receptor as a novel therapeutic target in asthma.

Authors:  Stephen T Holgate
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 3.  Cheyne-stokes respiration in patients with heart failure.

Authors:  Laila AlDabal; Ahmed S BaHammam
Journal:  Lung       Date:  2009-12-03       Impact factor: 2.584

4.  Plasma adenosine during investigation of hypoxic ventilatory response.

Authors:  Dirk Drumm; Markus Hoefer; Janos Juhász; Eva Huszár; Gerhard W Sybrecht
Journal:  Sleep Breath       Date:  2004-03       Impact factor: 2.816

5.  Purinergic modulation of preBötzinger complex inspiratory rhythm in rodents: the interaction between ATP and adenosine.

Authors:  J D Zwicker; V Rajani; L B Hahn; G D Funk
Journal:  J Physiol       Date:  2011-07-25       Impact factor: 6.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.